151 related articles for article (PubMed ID: 30813397)
1. VAS2870 Inhibits Histamine-Induced Calcium Signaling and vWF Secretion in Human Umbilical Vein Endothelial Cells.
Avdonin PV; Rybakova EY; Avdonin PP; Trufanov SK; Mironova GY; Tsitrina AA; Goncharov NV
Cells; 2019 Feb; 8(2):. PubMed ID: 30813397
[TBL] [Abstract][Full Text] [Related]
2. Enhancement by Hydrogen Peroxide of Calcium Signals in Endothelial Cells Induced by 5-HT1B and 5-HT2B Receptor Agonists.
Avdonin PV; Nadeev AD; Mironova GY; Zharkikh IL; Avdonin PP; Goncharov NV
Oxid Med Cell Longev; 2019; 2019():1701478. PubMed ID: 30886671
[TBL] [Abstract][Full Text] [Related]
3. Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells.
Stielow C; Catar RA; Muller G; Wingler K; Scheurer P; Schmidt HH; Morawietz H
Biochem Biophys Res Commun; 2006 May; 344(1):200-5. PubMed ID: 16603125
[TBL] [Abstract][Full Text] [Related]
4. Off-target thiol alkylation by the NADPH oxidase inhibitor 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo[4,5-d]pyrimidine (VAS2870).
Sun QA; Hess DT; Wang B; Miyagi M; Stamler JS
Free Radic Biol Med; 2012 May; 52(9):1897-902. PubMed ID: 22406319
[TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine kinases regulate agonist-stimulated prostacyclin release but not von Willebrand factor secretion from human umbilical vein endothelial cells.
Wheeler-Jones CP; May MJ; Morgan AJ; Pearson JD
Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):407-16. PubMed ID: 8615807
[TBL] [Abstract][Full Text] [Related]
6. Disruption of protein complexes containing protein phosphatase 2B and Munc18c reduces the secretion of von Willebrand factor from endothelial cells.
Da Q; Shaw T; Pradhan S; Roche PA; Cruz MA; Vijayan KV
J Thromb Haemost; 2017 May; 15(5):1032-1039. PubMed ID: 28294518
[TBL] [Abstract][Full Text] [Related]
7. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation.
ten Freyhaus H; Huntgeburth M; Wingler K; Schnitker J; Bäumer AT; Vantler M; Bekhite MM; Wartenberg M; Sauer H; Rosenkranz S
Cardiovasc Res; 2006 Jul; 71(2):331-41. PubMed ID: 16545786
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C-delta mediates von Willebrand factor secretion from endothelial cells in response to vascular endothelial growth factor (VEGF) but not histamine.
Lorenzi O; Frieden M; Villemin P; Fournier M; Foti M; Vischer UM
J Thromb Haemost; 2008 Nov; 6(11):1962-9. PubMed ID: 18752579
[TBL] [Abstract][Full Text] [Related]
9. Dopamine modulates von Willebrand factor secretion in endothelial cells via D2-D4 receptors.
Zarei S; Frieden M; Rubi B; Villemin P; Gauthier BR; Maechler P; Vischer UM
J Thromb Haemost; 2006 Jul; 4(7):1588-95. PubMed ID: 16839358
[TBL] [Abstract][Full Text] [Related]
10. Serotonin-induced secretion of von Willebrand factor from human umbilical vein endothelial cells via the cyclic AMP-signaling systems independent of increased cytoplasmic calcium concentration.
Schlüter T; Bohnensack R
Biochem Pharmacol; 1999 May; 57(10):1191-7. PubMed ID: 11230807
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Histamine-Induced Relaxation of Rat Aorta and Calcium Signaling in Endothelial Cells by Two-Pore Channel Blocker trans-NED19 and Hydrogen Peroxide.
Zharkich IL; Nadeev AD; Tsitrin EB; Goncharov NV; Avdonin PV
Izv Akad Nauk Ser Biol; 2016 Jul; (4):430-438. PubMed ID: 30251796
[TBL] [Abstract][Full Text] [Related]
12. NAADP links histamine H1 receptors to secretion of von Willebrand factor in human endothelial cells.
Esposito B; Gambara G; Lewis AM; Palombi F; D'Alessio A; Taylor LX; Genazzani AA; Ziparo E; Galione A; Churchill GC; Filippini A
Blood; 2011 May; 117(18):4968-77. PubMed ID: 21364192
[TBL] [Abstract][Full Text] [Related]
13. 5,6-DiHETE attenuates vascular hyperpermeability by inhibiting Ca
Hamabata T; Nakamura T; Tachibana Y; Horikami D; Murata T
J Lipid Res; 2018 Oct; 59(10):1864-1870. PubMed ID: 30076209
[TBL] [Abstract][Full Text] [Related]
14. Tspan18 is a novel regulator of the Ca
Noy PJ; Gavin RL; Colombo D; Haining EJ; Reyat JS; Payne H; Thielmann I; Lokman AB; Neag G; Yang J; Lloyd T; Harrison N; Heath VL; Gardiner C; Whitworth KM; Robinson J; Koo CZ; Di Maio A; Harrison P; Lee SP; Michelangeli F; Kalia N; Rainger GE; Nieswandt B; Brill A; Watson SP; Tomlinson MG
Haematologica; 2019 Sep; 104(9):1892-1905. PubMed ID: 30573509
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of NADPH oxidase reverses the over contraction of diabetic rat aorta.
Rehman AU; Dugic E; Benham C; Lione L; Mackenzie LS
Redox Biol; 2014; 2():61-4. PubMed ID: 25460721
[TBL] [Abstract][Full Text] [Related]
16. 20-Hydroxyeicosatetraenoic acid involved in endothelial activation and thrombosis.
Wang J; Li H; He J; Li B; Bao Q; Zhang X; Lv Z; Zhang Y; Han J; Ai D; Zhu Y
Am J Physiol Heart Circ Physiol; 2015 Jun; 308(11):H1359-67. PubMed ID: 25820395
[TBL] [Abstract][Full Text] [Related]
17. Shear stress regulates the SNAP23-mediated endothelial secretion of VWF through the GPR68/PKA/vimentin mechanotransduction pathway.
Jiang Z; Zhu J; Zhao C; Tang Y; Liu H; Zhao J; Zhang J; Liu Y; Yao W; Han L; Pang W; Zhou J
Biochem Biophys Res Commun; 2022 Jun; 607():166-173. PubMed ID: 35381387
[TBL] [Abstract][Full Text] [Related]
18. NADPH oxidase inhibitor VAS2870 prevents staurosporine-induced cell death in rat astrocytes.
Simenc J; Juric DM; Lipnik-Stangelj M
Radiol Oncol; 2019 Jan; 53(1):69-76. PubMed ID: 30661061
[TBL] [Abstract][Full Text] [Related]
19. Effect of NADPH oxidase inhibitors in an experimental retinal model of excitotoxicity.
Dionysopoulou S; Wikström P; Walum E; Thermos K
Exp Eye Res; 2020 Nov; 200():108232. PubMed ID: 32916159
[TBL] [Abstract][Full Text] [Related]
20. NADPH oxidase inhibitor improves outcome of mechanical reperfusion by suppressing hemorrhagic transformation.
Tuo YH; Liu Z; Chen JW; Wang QY; Li SL; Li MC; Dai G; Wang JS; Zhang YL; Feng L; Shi ZS
J Neurointerv Surg; 2017 May; 9(5):492-498. PubMed ID: 27075483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
